AMMARA RAZIUDDIN: Open Payments
NPI 1245765148 · WEST ALLIS, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $21 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
Products named: INGREZZA, CAPLYTA, AUSTEDO XR, SPRAVATO, REXULTI, VRAYLAR, Dyanavel XR.
Industry payments across WI — which companies pay providers there.
